 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || ICG134 / iCell Gene Therap
New P1 trial: CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies (clinicaltrials.gov) - Nov 14, 2019
P1, N=20, Recruiting, Sponsor: iCell Gene Therapeutics